Showing results (201-210 of 382) with videos related to

Sort By:
Pageof 39
Plos One|April 6, 2012
Phenotypic and functional properties of Helios+ regulatory T cellsDaniel J Zabransky, Christopher J Nirschl, Nicholas M Durham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewingKaren Sandell Sfanos, Tullia C Bruno, Charles H Maris, et al.
The Prostate|September 19, 2020
Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)Lauren C Harshman, Victoria X Wang, Anis A Hamid, et al.
Urologic Oncology|August 21, 2025
Molecular classification of nonurothelial histologic subtypes of bladder cancerMichelle I Higgins, Andrew T Gabrielson, Zhuo Tony Su, et al.
The Journal of Urology|October 24, 2024
Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, et al.
Oncoimmunology|July 29, 2016
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladderAlexander S Baras, Charles Drake, Jen-Jane Liu, et al.
European Urology|June 28, 2023
Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder CancerMingxiao Feng, Andres Matoso, Gabriel Epstein, et al.
Urologic Oncology|July 20, 2016
Accuracy of urethral frozen section during radical cystectomy for bladder cancerMax Kates, Mark W Ball, Meera R Chappidi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2014
A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE IINrupen A Bhavsar, Jay H Bream, Alan K Meeker, et al.
The Prostate|July 13, 2011
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancerDaniel J Zabransky, Heath A Smith, Christopher J Thoburn, et al.
Pageof 39